PICKED · PersonalIzed medicine in Chronic KidnEy Disease
„Хоризонт Европа“ — Действия „Мария Склодовска-Кюри“
- Период
- 2024-10-01 → 2028-09-30
- Финансиране от ЕС
- 2 671 855 €
- Участници
- 21
- Схема
- HORIZON-TMA-MSCA-DN
Линиите свързват координатора с партньорите.
Накратко на български
Персонализираната медицина при хроничните бъбречни заболявания търси начини за по-точно откриване и лечение на болестта чрез биомаркери и етични стандарти. Това е важно, защото състоянието засяга огромен брой хора и изисква по-добри методи за разпределяне на пациентите в групи.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Цел на проекта
In 2017, on a world scale the total number of individuals with chronic kidney disease, acute kidney injury, and those on renal replacement therapy exceeded 850 million, a truly concerning figure that is twice the estimated number of people with diabetes worldwide and >20 times higher than the number of individuals affected by AIDS/HIV worldwide. The socioeconomic impact of kidney disease is huge and is anticipated to even further grow in the coming years. Awareness of the magnitude and the risks of this condition have remained low at the population level. Therefore, kidney disease has been, until recently, largely overlooked by health authorities and governments in most countries with as the result accumulation of major unmet needs in personalized medicine in kidney disease. The aim of PICKED (PersonalIzed medicine in Chronic KidnEy Disease) is to equip a generation of 10 doctoral candidates (DC) with interdisciplinary skills for the development of pathways to implement personalized medicine in chronic kidney disease and their complications on the level of its detection, progression and treatment. We anticipate that these DCs will significantly contribute to the increasing possibilities to stratify patients with kidney disease and the development of successful intervention procedures with potential to substantially impact the lives of over 10% of the European population. PICKED will realize this aim by coordinating the efforts of 10 beneficiaries and 8 associated partners across 7 European countries and 3 sectors, with lead supervisors covering a large range of disciplines ranging from biomarker-research to research into the legal, ethical and quality of life aspects for the implementation of personalized medicine in kidney disease.
Оригинален текст от CORDIS (на английски).
Участници
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE · ParisКоординаторФранция
- DELTA 4 GMBH · WIENАвстрия
- ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON · ATHINAГърция
- EUROPEAN KIDNEY HEALTH ALLIANCE · Bruxelles / BrusselБелгия
- EUTOX -WORK GROUP (EUROPEAN UREMICTOXINS (EUTOX) WORK GROUP) E.V · AachenГермания
- Gesellschaft zur Förderung der Lebenswissenschaften Heidelberg GmbH · HeidelbergГермания
- IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON · AthinaГърция
- INSTITUTO INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ · MadridИспания
- KOBENHAVNS UNIVERSITET · KOBENHAVNДания
- MEDIZINISCHE UNIVERSITAT INNSBRUCK · InnsbruckАвстрия
- MOSAIQUES DIAGNOSTICS GMBH · HannoverГермания
- OPTOFLUID TECHNOLOGIES OÜ · TallinnЕстония
- RD NEPHROLOGIE SAS · MontpellierФранция
- REGION HOVEDSTADEN · HillerodДания
- TALLINNA TEHNIKAÜLIKOOL · TallinnЕстония
- UNIVERSIDAD AUTONOMA DE MADRID · MadridИспания
- UNIVERSITAT WIEN · WienАвстрия
- UNIVERSITATSKLINIKUM HEIDELBERG · HeidelbergГермания
- UNIVERSITE DE MONTPELLIER · MontpellierФранция
- UNIVERSITE DE TOULOUSE · ToulouseФранция
- UNIWERSYTET WROCLAWSKI · WroclawПолша
Връзки
Данни: CORDIS, © Европейски съюз